Genfit S.A. (GNFT.PA)

EUR 3.5

(2.04%)

Inventory Summary of Genfit S.A.

  • Genfit S.A.'s latest annual inventory in 2023 was 4000.00 EUR , down 0.0% from previous year.
  • Genfit S.A.'s latest quarterly inventory in 2024 Q2 was 4000.00 EUR , down 0.0% from previous quarter.
  • Genfit S.A. reported annual inventory of 4000.00 EUR in 2022, down 0.0% from previous year.
  • Genfit S.A. reported annual inventory of 4000.00 EUR in 2021, down 0.0% from previous year.
  • Genfit S.A. reported quarterly inventory of 4000.00 EUR for 2023 FY, down 0.0% from previous quarter.
  • Genfit S.A. reported quarterly inventory of 4000.00 EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Genfit S.A. (2023 - 2005)

Historical Annual Inventory of Genfit S.A. (2023 - 2005)

Year Inventory Inventory Growth
2023 4000.00 EUR 0.0%
2022 4000.00 EUR 0.0%
2021 4000.00 EUR 0.0%
2020 4000.00 EUR 0.0%
2019 4000.00 EUR 0.0%
2018 4000.00 EUR 0.0%
2017 4000.00 EUR -71.43%
2016 14 Thousand EUR -50.0%
2015 28 Thousand EUR -88.71%
2014 248 Thousand EUR 48.5%
2013 167 Thousand EUR 5.7%
2012 158 Thousand EUR -8.78%
2011 173.2 Thousand EUR -7.13%
2010 186.5 Thousand EUR -10.12%
2009 207.5 Thousand EUR 430.69%
2008 39.1 Thousand EUR 28.2%
2007 30.5 Thousand EUR -0.97%
2006 30.8 Thousand EUR 10.79%
2005 27.8 Thousand EUR 0.0%

Peer Inventory Comparison of Genfit S.A.

Name Inventory Inventory Difference
ABIONYX Pharma SA 221 Thousand EUR 98.19%
ABIVAX Société Anonyme 1.00 EUR -399900.0%
Adocia SA 272 Thousand EUR 98.529%
Aelis Farma SA 53 Thousand EUR 92.453%
Biophytis S.A. - EUR -Infinity%
Advicenne S.A. 1.74 Million EUR 99.77%
genOway Société anonyme 982.75 Thousand EUR 99.593%
IntegraGen SA 311.44 Thousand EUR 98.716%
Medesis Pharma S.A. 164.62 Thousand EUR 97.57%
Neovacs S.A. - EUR -Infinity%
NFL Biosciences SA -1.1 Million EUR 100.361%
Plant Advanced Technologies SA 1.22 Million EUR 99.673%
Quantum Genomics Société Anonyme -119.17 Thousand EUR 103.356%
Sensorion SA - EUR -Infinity%
Theranexus Société Anonyme - EUR -Infinity%
TME Pharma N.V. 91 Thousand EUR 95.604%
Valbiotis SA 1 Million EUR 99.602%
TheraVet SA 123.34 Thousand EUR 96.757%
Valerio Therapeutics Société anonyme 1.00 EUR -399900.0%
argenx SE 281.12 Million EUR 99.999%
BioSenic S.A. - EUR -Infinity%
Celyad Oncology SA 1.26 Million EUR 99.683%
DBV Technologies S.A. 1.00 USD -399900.0%
Galapagos NV 73.97 Million EUR 99.995%
GeNeuro SA - EUR -Infinity%
Hyloris Pharmaceuticals SA 1.00 EUR -399900.0%
Innate Pharma S.A. 1.00 EUR -399900.0%
Inventiva S.A. 417 Thousand EUR 99.041%
MaaT Pharma SA 190 Thousand EUR 97.895%
MedinCell S.A. -6.71 Million EUR 100.06%
Nanobiotix S.A. 200 Thousand EUR 98.0%
Onward Medical N.V. 936 Thousand EUR 99.573%
Oryzon Genomics S.A. 6029.00 EUR 33.654%
OSE Immunotherapeutics SA - EUR -Infinity%
Oxurion NV 128 Thousand EUR 96.875%
Pharming Group N.V. 51.38 Million EUR 99.992%
Poxel S.A. 2.95 Million EUR 99.865%
GenSight Biologics S.A. 1.00 EUR -399900.0%
Transgene SA - EUR -Infinity%
Financière de Tubize SA - EUR -Infinity%
UCB SA 1.03 Billion EUR 100.0%
Valneva SE 44.46 Million EUR 99.991%
Vivoryon Therapeutics N.V. 1.00 EUR -399900.0%